BioRegenx Inc
findit.comWhat Do They Do?
Develops and sells nutritional supplements, medical testing equipment, and diagnostic and wellness technology to consumers, health professionals, and research organizations.
10-K for FY2025, filed Apr 15, 2026The Company, through its subsidiaries, engages in research, development, and commercialization of dietary supplements, medical devices…View ↗
Revenue is generated from the sale of goods and services to doctors, healthcare practitioners, patients, consumers and wholesale…View ↗
The Company, BioRegenx, Inc., develops and manufactures medical test equipment and high quality, science-based nutritional products. The…View ↗
How Do They Make Money?
Customers generally pay by credit card before the company ships goods, usually within 24 hours of payment. It sells testing machines and consumables, wellness devices, and nutritional supplements; a few orders are exceptions to prepayment.
10-K for FY2025, filed Apr 15, 2026The Company through its subsidiaries provides a medical testing machine, consumables for the testing process, wellness devices and…View ↗
-
10-K for FY2025, filed Apr 15, 2026
FY2025 revenue by product or service ↗
$1.9M
-
10-K for FY2025, filed Apr 15, 2026
$1.9M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Medical Testing
Sold outright
10-K for FY2025, filed Apr 15, 2026 |
11% |
Medical Testing, FY2025
$207.9K Sources
|
Sold outright |
|
Wellness Devices
Sold outright
|
1.4% |
Wellness Devices, FY2025
$25.4K Sources
|
Sold outright |
|
Nutritional
Sold outright
10-K for FY2025, filed Apr 15, 2026 |
88% |
Nutritional, FY2025
$1.6M Sources
|
Sold outright |
|
Other Sales
|
0.1% |
Other Sales, FY2025
$884 Sources
|
Who Are Their Customers?
Medical and academic buyers, direct customers, and resellers buy the company’s products. Sales also go to doctors, healthcare practitioners, patients, consumers, and wholesale distributors.
10-K for FY2025, filed Apr 15, 2026
Do Revenues Turn Into Profits?
Not on paper. It lost $1.5M in FY2025, but brought in more cash than it spent: $29.9K of free cash flow.
10-K for FY2025, filed Apr 15, 2026
−$1.2MView ↗
10-K for FY2025, filed Apr 15, 2026
−$1.5MView ↗
10-K for FY2025, filed Apr 15, 2026
$29.9KView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q1 FY2026, filed May 20, 2026
−$26.4KView ↗
- ▼ −90% (Loss)
- vs −$266.9K in Q1 FY2025
10-Q for Q1 FY2026, filed May 20, 2026
Open tableView ↗
Growing. Revenue grew 9.3x in 4 years, from $198.6K in FY2021 to $1.9M in FY2025, about 75% a year.
From internet services to health products
The older report centers on Findit’s social media content platform, search tools, online marketing services, and CBD products. The latest report describes a business developing and selling nutritional products, medical test equipment, wellness devices, and health technology.
10-K for FY2022, filed Apr 4, 2023 10-K for FY2025, filed Apr 15, 2026We were incorporated on December 23, 1998 as Findit, Inc., a Nevada corporation. The Company owns Findit.com and the Findit App that is…View ↗
Search Engine Optimization- Findit provides online Search Engine Optimization services also known as SEO. Findit offers these services to…View ↗
The Company does provide B2C sales in the CBD space as well.View ↗
The Company, through its subsidiaries, engages in research, development, and commercialization of dietary supplements, medical devices…View ↗
Microvascular Health Solutions, LLC (MVHS) specializes in research, product development, sales, and education, notably producing the…View ↗
The Company, BioRegenx, Inc., develops and manufactures medical test equipment and high quality, science-based nutritional products. The…View ↗
Who Do They Compete With?
Competes with Alphabet, Microsoft, Meta Platforms, X, Zillow, Google, Bing, Yahoo, Teladoc Health, Amwell, and MDLIVE
10-K for FY2025, filed Apr 15, 2026We face significant competition across multiple aspects of our business, particularly from major technology and digital marketing companies…View ↗
Loading...
